SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: John F. Dowd who wrote (5761)10/1/1998 12:11:00 PM
From: Ron Flanigan  Read Replies (2) | Respond to of 9523
 
John F. Dowd--I'll wish for that happening.

PFE's only problem is the market in general and that has
pulled down even the pharmaceuticals.



To: John F. Dowd who wrote (5761)10/7/1998 12:55:00 AM
From: Tokyo VD  Read Replies (1) | Respond to of 9523
 
John,

You were too optimistic with PLC's FDA approval. The same applies in this case. The market for ED isn't as big as the HYPE, and Viagra sales aren't going to increase domestically Y/Y 50% like analysts hope.

Look for Cox-2 approval to be the next driver of the stock upward. If no approval, then watch out below.

Good luck.

Tokyo


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News